GADD45A plays a protective role against temozolomide treatment in glioblastoma cells
Abstract Glioblastoma multiforme (GBM) is one of the most aggressive cancers. Despite recent advances in multimodal therapies, high-grade glioma remains fatal. Temozolomide (TMZ) is an alkylating agent used worldwide for the clinical treatment of GBM; however, the innate and acquired resistance of G...
Guardado en:
Autores principales: | Hsiao-Han Wang, Tsuey-Yu Chang, Wei-Chen Lin, Kuo-Chen Wei, Jyh-Wei Shin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ee0ffa440bc41b78b22d295136c806d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas RP, et al.
Publicado: (2012) -
MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis.
por: Gyu-Tae Shin, et al.
Publicado: (2021) -
MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis
por: Gyu-Tae Shin, et al.
Publicado: (2021) -
Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis
por: Pedro Rodríguez-Jiménez, et al.
Publicado: (2021) -
Interplay of m6A and histone modifications contributes to temozolomide resistance in glioblastoma
por: Fuxi Li, et al.
Publicado: (2021)